Gabriel Heering[Author] - Search Results

Year	Number of Results
2020	1
2021	1
2022	5
2023	1
2024	1

1

Fontan-Associated Liver Disease: A Review.

Heering G, Lebovics N, Agarwal R, Frishman WH, Lebovics E. Heering G, et al. Cardiol Rev. 2024 Mar 13. doi: 10.1097/CRD.0000000000000684. Online ahead of print. Cardiol Rev. 2024. PMID: 38477576

2

Evaluation of the clinical impact of bone marrow cultures in current medical practice.

Sharvit G, Schwartz D, Heering G, Shulman A, Avigdor A, Rahav G, Toren A, Nagler A, Canaani J. Sharvit G, et al. Among authors: heering g. Sci Rep. 2022 Jun 11;12(1):9664. doi: 10.1038/s41598-022-14059-3. Sci Rep. 2022. PMID: 35690634 Free PMC article.

3

Contemporary evaluation of acute myeloid leukemia patients with long-term survival exceeding 5 years.

Heering G, Sasson M, Dominissini D, Shimoni A, Avigdor A, Nagler A, Canaani J. Heering G, et al. Eur J Haematol. 2022 Dec;109(6):765-771. doi: 10.1111/ejh.13864. Epub 2022 Oct 1. Eur J Haematol. 2022. PMID: 36128925

4

Metastatic Squamous Cell Carcinoma of the Lung Disclosed From Constipation Workup.

Lin ZX, Weiss A, Lee KI, Heering G, Chang L, Pais S. Lin ZX, et al. Among authors: heering g. ACG Case Rep J. 2023 Aug 30;10(9):e01133. doi: 10.14309/crj.0000000000001133. eCollection 2023 Sep. ACG Case Rep J. 2023. PMID: 37654618 Free PMC article.

5

Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol.

Fredman D, Moshe Y, Wolach O, Heering G, Shichrur K, Goldberg I, Hofstetter L, Neaman M, Scheib T, Marcu-Malina V, Avigdor A, Shimoni A, Nagler A, Canaani J. Fredman D, et al. Among authors: heering g. Ann Hematol. 2022 Mar;101(3):581-593. doi: 10.1007/s00277-021-04738-y. Epub 2022 Jan 28. Ann Hematol. 2022. PMID: 35088172

6

ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy.

Keren-Froim N, Heering G, Sharvit G, Zlotnik M, Nagler A, Shimoni A, Avigdor A, Canaani J. Keren-Froim N, et al. Among authors: heering g. Ann Hematol. 2022 Feb;101(2):309-316. doi: 10.1007/s00277-021-04716-4. Epub 2022 Jan 6. Ann Hematol. 2022. PMID: 34989829

7

Acute Myeloid Leukemia Patients Requiring Two Cycles of Intensive Induction for Attainment of Remission Experience Inferior Survival Compared with Patients Requiring a Single Course of Induction Chemotherapy.

Sharvit G, Heering G, Zlotnik M, Merkel D, Nagler A, Avigdor A, Shimoni A, Canaani J. Sharvit G, et al. Among authors: heering g. Clin Lymphoma Myeloma Leuk. 2022 Feb;22(2):e116-e123. doi: 10.1016/j.clml.2021.08.014. Epub 2021 Sep 9. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34593360

8

Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia.

Canaani J, Nagar M, Heering G, Gefen C, Yerushalmi R, Shem-Tov N, Volchek Y, Merkel D, Avigdor A, Shimoni A, Amariglio N, Rechavi G, Nagler A. Canaani J, et al. Among authors: heering g. Oncotarget. 2020 Jun 9;11(23):2233-2245. doi: 10.18632/oncotarget.27618. eCollection 2020 Jun 9. Oncotarget. 2020. PMID: 32577167 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year